NYSE:CFX - Colfax Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $42.45
  • Forecasted Upside: -6.33 %
  • Number of Analysts: 9
  • Breakdown:
  • 1 Sell Ratings
  • 3 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$45.32
▲ +0.12 (0.27%)

This chart shows the closing price for CFX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Colfax Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CFX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CFX

Analyst Price Target is $42.45
▼ -6.33% Downside Potential
This price target is based on 9 analysts offering 12 month price targets for Colfax in the last 3 months. The average price target is $42.45, with a high forecast of $57.00 and a low forecast of $6.50. The average price target represents a -6.33% upside from the last price of $45.32.

This chart shows the closing price for CFX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 9 polled investment analysts is to hold stock in Colfax. This rating has held steady since February 2021, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 12 buy ratings
  • 4 hold ratings
  • 1 sell ratings
2/2/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 4 hold ratings
  • 2 sell ratings
5/2/2020
  • 0 strong buy ratings
  • 11 buy ratings
  • 4 hold ratings
  • 2 sell ratings
7/31/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 3 hold ratings
  • 2 sell ratings
10/29/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 3 hold ratings
  • 2 sell ratings
1/27/2021
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 2 sell ratings
4/27/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 1 sell ratings
6/26/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 1 sell ratings
7/26/2021

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/30/2021Morgan StanleyBoost Price TargetEqual Weight$45.00 ➝ $47.00Low
4/13/2021BarclaysReiterated RatingEqual Weight ➝ Underweight$48.00 ➝ $45.00Low
4/12/2021Morgan StanleyBoost Price TargetEqual Weight$42.00 ➝ $45.00Low
4/6/2021BarclaysDowngradeEqual Weight ➝ Underweight$48.00 ➝ $45.00Low
3/12/2021Deutsche Bank AktiengesellschaftBoost Price TargetHold$53.00 ➝ $54.00Medium
3/12/2021KeyCorpBoost Price TargetOverweight$47.00 ➝ $57.00Medium
3/5/2021Deutsche Bank AktiengesellschaftBoost Price TargetHold$41.00 ➝ $43.00High
2/25/2021Morgan StanleyBoost Price TargetEqual Weight$39.00 ➝ $42.00Low
2/22/2021CitigroupBoost Price Target$35.00 ➝ $41.00Low
2/19/2021BarclaysBoost Price TargetEqual Weight$35.00 ➝ $40.00High
12/15/2020Morgan StanleyBoost Price TargetEqual Weight$30.00 ➝ $39.00Low
11/24/2020JPMorgan Chase & Co.Reiterated RatingBuy$52.00High
11/18/2020KeyCorpBoost Price TargetOverweight$36.00 ➝ $44.00High
11/9/2020UBS GroupUpgradeNeutral ➝ Buy$36.00 ➝ $40.00High
9/16/2020Bank of AmericaBoost Price TargetBuy$40.00 ➝ $42.00High
9/15/2020UBS GroupInitiated CoverageNeutral$36.00High
8/13/2020ArgusBoost Price TargetBuy$32.00 ➝ $40.00Low
8/7/2020Morgan StanleyBoost Price TargetEqual Weight$28.00 ➝ $33.00High
8/7/2020KeyCorpBoost Price TargetOverweight$33.00 ➝ $36.00High
7/27/2020TD SecuritiesBoost Price TargetHold$6.00 ➝ $6.50Medium
7/7/2020BarclaysBoost Price TargetEqual Weight$31.00 ➝ $33.00Low
5/29/2020JPMorgan Chase & Co.Initiated CoverageOverweight$32.00Low
5/11/2020Northcoast ResearchUpgradeNeutral ➝ Buy$38.00High
5/8/2020Stifel NicolausBoost Price TargetBuy$30.00 ➝ $32.00Low
5/8/2020Robert W. BairdBoost Price TargetOutperform$31.00 ➝ $33.00Low
5/8/2020Morgan StanleyBoost Price TargetEqual Weight$23.00 ➝ $28.00High
5/8/2020Deutsche Bank AktiengesellschaftBoost Price TargetHold$19.00 ➝ $30.00High
5/8/2020CitigroupBoost Price TargetSell$18.00 ➝ $21.00High
4/15/2020Morgan StanleyBoost Price TargetEqual Weight$14.00 ➝ $23.00High
4/9/2020Deutsche Bank AktiengesellschaftLower Price TargetHold$41.00 ➝ $19.00High
4/1/2020CitigroupLower Price TargetSell$29.00 ➝ $18.00Medium
3/17/2020Morgan StanleyLower Price TargetEqual Weight$37.00 ➝ $27.00High
2/24/2020CowenBoost Price TargetOutperform$40.00 ➝ $50.00High
2/24/2020KeyCorpBoost Price TargetOverweight$42.00 ➝ $45.00High
1/16/2020The Goldman Sachs GroupInitiated CoverageBuy$44.00High
1/13/2020CIBCUpgradeOutperformer$10.00 ➝ $12.00High
12/19/2019Robert W. BairdBoost Price TargetOutperform$39.00 ➝ $42.00Medium
12/19/2019KeyCorpBoost Price TargetOverweight$39.00 ➝ $42.00Medium
12/17/2019Bank of AmericaUpgradeNeutral ➝ BuyMedium
12/4/2019Deutsche Bank AktiengesellschaftBoost Price TargetHold$36.00 ➝ $37.00High
11/27/2019BarclaysInitiated CoverageEqual Weight$36.00Low
11/22/2019Stifel NicolausReiterated RatingBuy$37.00Low
11/4/2019CowenBoost Price TargetOutperform$36.00 ➝ $40.00High
11/4/2019Bank of AmericaUpgradeUnderperform ➝ Neutral$27.00 ➝ $37.00High
10/25/2019CIBCLower Price Target$11.00 ➝ $10.00Low
10/25/2019TD SecuritiesLower Price TargetBuy$12.00 ➝ $11.00Low
10/24/2019Royal Bank of CanadaLower Price TargetSector Perform$10.00 ➝ $9.00Low
10/24/2019Raymond JamesReiterated RatingOutperform$18.00Low
9/26/2019ScotiabankUpgradeSector OutperformMedium
8/12/2019Seaport Global SecuritiesReiterated RatingBuyMedium
8/7/2019Stifel NicolausSet Price TargetBuy$35.00Low
8/7/2019KeyCorpLower Price TargetOverweight$40.00 ➝ $37.00High
7/10/2019Deutsche Bank AktiengesellschaftSet Price TargetHold$28.00High
7/10/2019Morgan StanleyLower Price TargetEqual Weight$30.00 ➝ $29.00Medium
6/7/2019CIBCReiterated RatingHold$15.00Low
5/2/2019Raymond JamesReiterated RatingBuy$21.00High
4/22/2019Raymond JamesReiterated RatingBuy$21.00Low
4/5/2019The Goldman Sachs GroupInitiated CoverageNeutral ➝ Buy$34.00Low
3/21/2019Longbow ResearchReiterated RatingBuy$38.00Low
3/15/2019BarclaysUpgradeUnderweight ➝ Equal Weight$28.70High
2/22/2019Raymond JamesReiterated RatingBuy$25.00Low
2/14/2019GabelliReiterated RatingBuyLow
2/14/2019OppenheimerReiterated RatingBuyLow
1/14/2019CIBCReiterated RatingHold ➝ Average$20.00Low
12/20/2018OppenheimerLower Price TargetOutperform$37.00 ➝ $30.00Low
12/19/2018Stifel NicolausReiterated RatingBuy$31.00Low
12/17/2018BarclaysLower Price TargetUnderweight ➝ Underweight$25.00 ➝ $23.00Medium
11/19/2018OppenheimerReiterated RatingBuyMedium
10/30/2018Morgan StanleyLower Price TargetEqual Weight ➝ Hold$34.00 ➝ $32.00Low
10/29/2018Robert W. BairdReiterated RatingBuy$35.00Low
10/29/2018ArgusLower Price TargetBuy ➝ Buy$40.00 ➝ $34.00Medium
10/26/2018Deutsche Bank AktiengesellschaftSet Price TargetHold$30.00Low
10/25/2018OppenheimerReiterated RatingBuy$42.00 ➝ $37.00High
10/8/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$37.00 ➝ $40.00Low
9/28/2018Deutsche Bank AktiengesellschaftBoost Price TargetHold ➝ Hold$36.00 ➝ $38.00Low
9/4/2018CIBCUpgradeMarket Perform ➝ OutperformHigh
9/4/2018OppenheimerUpgradeMarket Perform ➝ Outperform$42.00High
9/4/2018UBS GroupUpgradeMarket Perform ➝ OutperformHigh
8/20/2018Morgan StanleyInitiated CoverageEqual ➝ Equal Weight$34.00Medium
8/17/2018CowenUpgradeMarket Perform ➝ OutperformHigh
8/8/2018BarclaysBoost Price TargetUnderweight ➝ Underweight$29.00 ➝ $30.00Low
8/6/2018Robert W. BairdReiterated RatingOutperform ➝ Buy$36.00 ➝ $38.00Medium
8/6/2018OppenheimerReiterated RatingHoldHigh
7/12/2018Deutsche Bank AktiengesellschaftSet Price TargetHold ➝ Hold$33.00Medium
6/4/2018Bank of AmericaDowngradeBuy ➝ Underperform$46.00 ➝ $32.00High
5/4/2018KeyCorpLower Price TargetOverweight ➝ Overweight$44.00 ➝ $40.00N/A
5/4/2018CitigroupLower Price TargetSell ➝ Sell$30.00 ➝ $28.00High
5/4/2018Stifel NicolausLower Price TargetBuy ➝ Buy$40.00 ➝ $37.00High
5/4/2018Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$43.00High
5/3/2018OppenheimerReiterated RatingHoldHigh
4/9/2018CitigroupLower Price TargetSell ➝ Sell$35.00 ➝ $30.00Medium
4/4/2018Robert W. BairdReiterated RatingBuy$39.00Medium
2/22/2018ArgusReiterated RatingBuy$40.00 ➝ $33.36Low
2/15/2018BarclaysInitiated CoverageUnderweight ➝ UnderweightLow
2/7/2018Seaport Global SecuritiesReiterated RatingBuyHigh
2/7/2018Robert W. BairdLower Price TargetOutperform ➝ Outperform$47.00 ➝ $42.00Low
2/7/2018GabelliUpgradeHold ➝ BuyMedium
2/7/2018KeyCorpLower Price TargetOverweight ➝ Overweight$46.00 ➝ $44.00Medium
2/7/2018Stifel NicolausLower Price TargetBuy ➝ Buy$48.00 ➝ $40.00Low
1/16/2018Stifel NicolausReiterated RatingBuy$44.00 ➝ $48.00Medium
12/11/2017Stifel NicolausReiterated RatingBuy$44.00Low
11/30/2017OppenheimerReiterated RatingHoldLow
11/21/2017Longbow ResearchUpgradeNeutral ➝ BuyN/A
11/7/2017Royal Bank of CanadaReiterated RatingBuy$44.00N/A
10/27/2017Robert W. BairdReiterated RatingBuy$50.00N/A
10/18/2017CowenDowngradeOutperform ➝ Market PerformN/A
10/17/2017Stifel NicolausReiterated RatingBuy$50.00N/A
10/9/2017CitigroupReiterated RatingSell$39.00 ➝ $40.00N/A
9/27/2017Royal Bank of CanadaReiterated RatingBuy$45.00Low
9/26/2017KeyCorpReiterated RatingBuy$46.00Low
9/26/2017CowenReiterated RatingBuy$50.00Low
8/29/2017ArgusReiterated RatingBuy$50.00Low
8/25/2017KeyCorpUpgradeSector Weight ➝ Overweight$46.00High
7/31/2017Robert W. BairdUpgradeNeutral ➝ Outperform$47.00 ➝ $50.00High
7/14/2017CowenReiterated RatingOutperform$45.00 ➝ $50.00Low
7/11/2017Wolfe ResearchInitiated CoverageMarket PerformLow
6/14/2017Seaport Global SecuritiesReiterated RatingBuyLow
5/24/2017CIBCReiterated RatingHoldLow
5/23/2017OppenheimerReiterated RatingHoldLow
5/18/2017Credit Suisse GroupInitiated CoverageOutperform ➝ Outperform$47.00Low
5/8/2017Robert W. BairdBoost Price TargetNeutral$47.00 ➝ $48.00Low
5/7/2017OppenheimerReiterated RatingHoldMedium
5/6/2017BarclaysSet Price TargetHold$40.00Medium
4/19/2017BarclaysBoost Price TargetEqual Weight$38.00 ➝ $39.00Low
4/17/2017Royal Bank of CanadaReiterated RatingBuy$44.00Low
3/24/2017Royal Bank of CanadaReiterated RatingBuy$43.00Medium
2/3/2017BarclaysReiterated RatingNeutral ➝ HoldN/A
2/3/2017Stifel NicolausBoost Price TargetBuy$42.00 ➝ $45.00N/A
2/1/2017Seaport Global SecuritiesUpgradeAccumulate ➝ BuyN/A
1/31/2017ArgusUpgradeHold ➝ BuyN/A
1/13/2017Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$32.00 ➝ $43.00N/A
11/14/2016ArgusUpgradeHold ➝ BuyN/A
10/28/2016Stifel NicolausBoost Price TargetBuy$33.00 ➝ $37.00N/A
7/29/2016CitigroupBoost Price TargetSell$25.00 ➝ $26.00N/A
(Data available from 7/26/2016 forward)
Colfax logo
Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the infrastructure, wind power, marine/life sciences, pipelines, mobile/off-highway equipment, oil, gas, and mining markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and direct and independent distributors under the DJO brand. Colfax Corporation was founded in 1860 and is headquartered in Annapolis Junction, Maryland.
Read More

Today's Range

Now: $45.32
Low: $45.21
High: $45.62

50 Day Range

MA: $45.16
Low: $42.74
High: $46.98

52 Week Range

Now: $45.32
Low: $26.45
High: $50.26

Volume

9,672 shs

Average Volume

1,348,073 shs

Market Capitalization

$6.15 billion

P/E Ratio

110.54

Dividend Yield

N/A

Beta

2.2

Frequently Asked Questions

What sell-side analysts currently cover shares of Colfax?

The following Wall Street sell-side analysts have issued reports on Colfax in the last twelve months: Argus, Bank of America Co., Barclays PLC, Citigroup Inc., Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., KeyCorp, Morgan Stanley, TD Securities, TheStreet, and UBS Group AG.
View the latest analyst ratings for CFX.

What is the current price target for Colfax?

10 Wall Street analysts have set twelve-month price targets for Colfax in the last year. Their average twelve-month price target is $42.45, suggesting a possible downside of 6.6%. KeyCorp has the highest price target set, predicting CFX will reach $57.00 in the next twelve months. TD Securities has the lowest price target set, forecasting a price of $6.50 for Colfax in the next year.
View the latest price targets for CFX.

What is the current consensus analyst rating for Colfax?

Colfax currently has 1 sell rating, 3 hold ratings and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CFX, but not buy more shares or sell existing shares.
View the latest ratings for CFX.

What other companies compete with Colfax?

How do I contact Colfax's investor relations team?

Colfax's physical mailing address is 420 NATIONAL BUSINESS PARKWAY 5TH FLOOR, ANNAPOLIS JUNCTION MD, 20701. The industrial products company's listed phone number is 301-323-9000 and its investor relations email address is [email protected] The official website for Colfax is www.colfaxcorp.com.